08:50 EDT Adverum Biotechnologies (ADVM) trading resumes
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ADVM:
- Eli Lilly to acquire Adverum Biotechnologies for up to $12.47 per share
- Adverum Biotechnologies trading halted, news pending
- Positive Outlook for Adverum Biotechnologies: Buy Rating Based on Promising ixo-vec Therapy and Strategic Financing Plans
- 3 Best Stocks to Buy Now, 9/23/2025, According to Top Analysts
- Buy Rating for Adverum Biotechnologies: Promising Phase 3 Trial Progress and Financial Resilience